Patents Assigned to University of Strathclyde
  • Patent number: 12188967
    Abstract: The invention enables an optical voltage sensor, comprising a piezoelectric actuator mechanically coupled to an optical strain sensor (such as a fibre Bragg grating), to withstand lightning impulses, the effects of which would otherwise be harmful or destructive to the piezoelectric actuator and/or other sensitive components. As such, the optical voltage sensor, comprised within a photonic voltage transducer which also comprises a lightning impulse attenuator, is able to comply with relevant standards and be used for applications in power networks and exposed to the highest voltages for equipment.
    Type: Grant
    Filed: December 22, 2020
    Date of Patent: January 7, 2025
    Assignee: University of Strathclyde
    Inventors: Pawel Niewczas, Grzegorz Fusiek
  • Publication number: 20240403685
    Abstract: A method of performing a quantum gate operation using a quantum system wherein the quantum system comprises two or more neutral atoms, wherein each atom of the two or more neutral atoms is configured to transition between atomic states comprising: a first hyperfine ground state of the atom, a second hyperfine ground state of the atom, a Rydberg state and at least one intermediate excited state, wherein the quantum system further comprises an interaction between the Rydberg states of the two or more neutral atoms, and wherein the method comprises: generating a pulse sequence and providing the generated pulse sequence to the two or more neutral atoms to transition the atoms between said atomic states, wherein the pulse sequence takes into account at least part of the hyperfine structure of the at least one intermediate atomic state.
    Type: Application
    Filed: June 13, 2024
    Publication date: December 5, 2024
    Applicant: University of Strathclyde
    Inventors: Gerard Pelegri, Andrew Daley, Jonathan Pritchard
  • Patent number: 12138486
    Abstract: A medical system for providing radiotherapy is disclosed. The system comprises a particle accelerator configured to produce a radiation beam and irradiate at least a part of a subject with the radiation beam. The particle accelerator comprises a plasma zone comprising or configured to receive a plasma, and at least one beam source configured to provide an excitation beam along an axis through the plasma zone.
    Type: Grant
    Filed: September 25, 2020
    Date of Patent: November 12, 2024
    Assignee: University of Strathclyde
    Inventors: Panagiotis Delinikolas, Bernhard Hidding, Fahim Ahmad Habib
  • Publication number: 20240252697
    Abstract: Disclosed herein are methods and devices for the inactivation of pathogens (e.g., bacteria, viruses, etc.) in ex vivo stored blood products, such as plasma and/or platelets, by means of directing visible light radiation from an illuminating device into blood product storage containers in order to achieve effective pathogen inactivation without the presence of an added photosensitising agent in the blood product. An exemplary apparatus includes a control unit that operates a light source that emits light in the wavelength region of about 380-500 nm which is directed onto blood product storage bags at sufficient intensity to penetrate the bag material and the opaque blood product therein in order to inactivate pathogens in the blood product but at dose levels that cause no significant detrimental effects on the blood product.
    Type: Application
    Filed: April 8, 2024
    Publication date: August 1, 2024
    Applicants: The United States of America, as represented by the Secretary, Department of Health and Human Se, The University of Strathclyde
    Inventors: Chintamani Atreya, Michelle Maclean, John G. Anderson, Scott J. MacGregor
  • Patent number: 12044639
    Abstract: An atomic magnetometer system is disclosed that includes a variable magnetic field source (14) configured to provide an oscillating primary magnetic field to cause a sample (16) to produce a secondary magnetic field. The atomic magnetometer system also includes an atomic magnetometer for detecting the secondary magnetic field. The atomic magnetometer includes an atomic specimen, a pump and probe subsystem configured to pump the atomic specimen to create a polarisation and to probe atomic coherence precession within the atomic specimen with a probe beam, a detector configured to detect the probe beam to produce a detection signal. The system is configured to drive the variable magnetic field source (14) in dependence on the detection signal with a frequency tuned to rf resonance. A method of operating an atomic magnetometer is also disclosed.
    Type: Grant
    Filed: July 17, 2020
    Date of Patent: July 23, 2024
    Assignees: NPL Management Limited, The University of Strathclyde
    Inventors: Witold Chalupczak, Rafal Gartman, Patrick Bevington
  • Patent number: 11964944
    Abstract: Disclosed herein are novel compounds for treating apicomplexan parasite related disorders, methods for their use; cell line and non-human animal models of the dormant parasite phenotype and methods for their use in identifying new drugs to treat apicomplexan parasite related disorders, and biomarkers to identify disease due to the parasite and its response to treatment.
    Type: Grant
    Filed: June 2, 2022
    Date of Patent: April 23, 2024
    Assignees: The University of Chicago, J. Craig Venter Institute, Inc., The University of Sheffield, Institute for Systems Biology, The University of Leeds, The University of Strathclyde, The Government of the United States
    Inventors: Rima McLeod, Martin McPhillie, Colin W. G. Fishwick, Hernan Alejandro Lorenzi, Kai Wang, Taek-Kyun Kim, Yong Zhou, Leroy E. Hood, Ying Zhou, Kamal El Bissati, Mark Hickman, QiGui Li, Craig Roberts
  • Patent number: 11885302
    Abstract: A vertical axis turbine having a first rotor and at least one second rotor, the first rotor being configured to rotate around a first rotation axis that is vertical or more vertical than horizontal. The first rotor may be configured to be driven and/or rotated by wind or water flow. The at least one second rotor is provided on or coupled to the first rotor such that the first rotor is operable to move the second rotor upon rotation of the first rotor. The second rotor is operable to drive a power take off system. Each second rotor rotates around a respective second rotation axis that may be angled or perpendicular to the first rotation axis of the first rotor. The first and second rotors are configured so that the power take-off system can be driven without the need for a gearbox.
    Type: Grant
    Filed: September 27, 2019
    Date of Patent: January 30, 2024
    Assignee: University of Strathclyde
    Inventors: James Carroll, William Edward Leithead
  • Publication number: 20230024557
    Abstract: The invention enables an optical voltage sensor, comprising a piezoelectric actuator mechanically coupled to an optical strain sensor (such as a fibre Bragg grating), to withstand lightning impulses, the effects of which would otherwise be harmful or destructive to the piezoelectric actuator and/or other sensitive components. As such, the optical voltage sensor, comprised within a photonic voltage transducer which also comprises a lightning impulse attenuator, is able to comply with relevant standards and be used for applications in power networks and exposed to the highest voltages for equipment.
    Type: Application
    Filed: December 22, 2020
    Publication date: January 26, 2023
    Applicant: University of Strathclyde
    Inventors: Pawel NIEWCZAS, Grzegorz FUSIEK
  • Patent number: 11524080
    Abstract: The invention relates to methods for the preparation of a pharmaceutical-vesicle formulation comprising steps of: preparing and processing vesicle components and a pharmaceutical agent to entrap the pharmaceutical agent in the vesicle and form a pharmaceutical-vesicle formulation, wherein the pharmaceutical-vesicle formulation is reconstituted in a known quantity of the pharmaceutical agent dissolved in a pharmaceutically-acceptable carrier to provide a biphasic pharmaceutical-vesicle formulation. The invention also relates to the associated pharmaceutical-vesicle formulations, pharmaceutical kits and uses as a medicament, in particular for the prevention or treatment of infection by bacteria such as Burkholderia pseudomallei and Francisella tularensis, and viruses such as Venezuelan Equine Encephalitis Virus (VEEV).
    Type: Grant
    Filed: September 13, 2019
    Date of Patent: December 13, 2022
    Assignees: The Secretary of State for Defence, The University of Strathclyde
    Inventors: Ethel Diane Williamson, Riccardo Vincenzo D'Elia, Craig William Roberts, Stuart Woods
  • Patent number: 11497671
    Abstract: An apparatus (10) for the rehabilitation, assistance and/or augmentation of arm strength in a user (U) comprises a support arrangement (12) for supporting the apparatus (10) on the user (U), a linkage arrangement (14) coupled to the support arrangement (12) and for coupling to an arm (A) of the user (U), and an actuation arrangement (16) for operating the linkage arrangement (14) and thereby manipulating the user's arm (A) in response to a user input signal.
    Type: Grant
    Filed: October 2, 2018
    Date of Patent: November 15, 2022
    Assignee: University of Strathclyde
    Inventors: Heba Lakany, Lijo Varughese Chacko
  • Publication number: 20220273834
    Abstract: Disclosed herein are methods and devices for the inactivation of pathogens (e.g., bacteria, viruses, etc.) in ex vivo stored blood products, such as plasma and/or platelets, by means of directing visible light radiation from an illuminating device into blood product storage containers in order to achieve effective pathogen inactivation without the presence of an added photosensitising agent in the blood product. An exemplary apparatus includes a control unit that operates a light source that emits light in the wavelength region of about 380-500 nm which is directed onto blood product storage bags at sufficient intensity to penetrate the bag material and the opaque blood product therein in order to inactivate pathogens in the blood product but at dose levels that cause no significant detrimental effects on the blood product.
    Type: Application
    Filed: May 20, 2022
    Publication date: September 1, 2022
    Applicants: The United States of America, as represented by the Secretary, Department of Health and Human Servic, The University of Strathclyde
    Inventors: Chintamani Atreya, Michelle Maclean, John G. Anderson, Scott J. MacGregor
  • Patent number: 11021516
    Abstract: A self-assembling peptide is provided that is enzymatically oxidized to form a polymeric pigment. The monomeric peptide has three amino acids (tyrosine (Y), one phenylalanine (F), and one aspartic acid (D) or one lysine (K)) and, following self-assembly and treatment with a tyrosinase enzyme oxidizes and polymerizes into a material with predetermined properties.
    Type: Grant
    Filed: September 11, 2017
    Date of Patent: June 1, 2021
    Assignees: Research Foundation of the City University of New York, University of Strathclyde, Carnegie Mellon University
    Inventors: Rein V. Ulijn, Ayala Lampel, Tell Tuttle, Gary Scott, Scott McPhee, Christopher Bettinger
  • Patent number: 11013100
    Abstract: A method of accelerating charged particles in a plasma and an associated plasma accelerator and electromagnetic radiation source, the method including creating a region of non-uniform electric field within the plasma which propagates through the plasma; using the non-uniform electric field to accelerate a first plurality of charged particles in the direction of propagation of the region of non-uniform electric field; and once the accelerating first plurality of charged particles have propagated part-way through the plasma: adding a second plurality of charged particles to the plasma, such that the second plurality of charged particles propagates through the plasma, the second plurality of charged particles create a local distortion in the non-uniform electric field experienced by the accelerating first plurality of charged particles, and the local distortion in the non-uniform electric field propagates through the plasma with the accelerating first plurality of charged particles; and the method also including
    Type: Grant
    Filed: September 29, 2017
    Date of Patent: May 18, 2021
    Assignee: University of Strathclyde
    Inventors: Bernhard Hidding, Grace Manahan, Fahim Ahmad Habib, Paul Scherkl
  • Patent number: 10966858
    Abstract: A support and corresponding system and method of using and producing the support, the support being for supporting a joint or body part of a wearer, the support having at least one rigid first support member, at least one fixing device for attaching the support to the wearer, and at least one second support member extending at an angle from the first support member.
    Type: Grant
    Filed: August 19, 2015
    Date of Patent: April 6, 2021
    Assignee: University of Strathclyde
    Inventors: Karyn Ross, Emma Henderson, Mark O'Hare, Nicola J. Cairns, Alejandra Aranceta Garza
  • Patent number: 10953117
    Abstract: A method for inactivating medically important Gram-positive bacteria including Methicillin-resistant Staphylococcus aureus (MRSA), Coagulase-Negative Staphylococcus (CONS), Streptococcus, Enterococcus and Clostridium species, comprising exposure to visible light, and in particular light within the wavelength range 400-500 nm.
    Type: Grant
    Filed: November 8, 2017
    Date of Patent: March 23, 2021
    Assignee: University of Strathclyde
    Inventors: John Galloway Anderson, Michelle Maclean, Gerald Alexander Woolsey, Scott John MacGregor
  • Patent number: 10849768
    Abstract: A prosthesis socket casting device having a housing and a flexible membrane for receiving a residual limb, the housing and the membrane defining a cavity for containing a fluid. Within the housing are means that are a function of the patient's weight for altering the distribution of the reactive fluid pressure applied when the residual limb is received within the membrane. In a preferred embodiment, the altering means comprise a movable piston that is provided at a lower end of the housing.
    Type: Grant
    Filed: March 11, 2016
    Date of Patent: December 1, 2020
    Assignee: University of Strathclyde
    Inventor: Arjan Buis
  • Patent number: 10716490
    Abstract: A wound sensor comprising at least one electrode (10a, 10b) and a non-adherent porous layer (25) proximate at least part of the electrode.
    Type: Grant
    Filed: July 9, 2010
    Date of Patent: July 21, 2020
    Assignee: University of Strathclyde
    Inventor: Patricia Connolly
  • Patent number: 10234282
    Abstract: The present invention refers to a method for determining a position of a divergent radiation source (1), comprising Irradiating a pixel detector (2) with a predetermined intensity distribution of radiation with wavelength ? originated from the radiation source (1), wherein the pixel detector (2) comprises a plurality of pixels with pixel coordinates (xi, yi, zi); Detecting, for each of the plurality of pixels, an intensity of the incident radiation (10); Determining, for each of the plurality of pixels, an incidence direction of the incident radiation using information on an orientation of an internal periodic structure at the pixel and the predetermined intensity distribution, wavelength ? and the detected intensity; and Determining the position (xp, yp, zp) of the radiation source (1) using the pixel coordinates (xi, yi, zi) and the incidence direction for each of the plurality of pixels.
    Type: Grant
    Filed: July 6, 2017
    Date of Patent: March 19, 2019
    Assignees: Brunker Nano GmbH, University of Strathclyde
    Inventors: Aimo Winkelmann, Stefano Vespucci
  • Publication number: 20190070323
    Abstract: Disclosed herein are methods and devices for the inactivation of pathogens (e.g., bacteria, viruses, etc.) in ex vivo stored blood products, such as plasma and/or platelets, by means of directing visible light radiation from an illuminating device into blood product storage containers in order to achieve effective pathogen inactivation without the presence of an added photosensitising agent in the blood product. An exemplary apparatus includes a control unit that operates a light source that emits light in the wavelength region of about 380-500 nm which is directed onto blood product storage bags at sufficient intensity to penetrate the bag material and the opaque blood product therein in order to inactivate pathogens in the blood product but at dose levels that cause no significant detrimental effects on the blood product.
    Type: Application
    Filed: September 29, 2016
    Publication date: March 7, 2019
    Applicants: The US of America, as represented by the Secretary Dept. of Health and Human Servics, The University of Strathclyde
    Inventors: Chintamani Atreya, Michelle Maclean, John G. Anderson, Scott J. MacGregor
  • Patent number: 10197393
    Abstract: The present invention refers to a method for determining a position of a divergent radiation source (1), comprising Irradiating a pixel detector (2) with a predetermined intensity distribution of radiation with wavelength ? originated from the radiation source (1), wherein the pixel detector (2) comprises a plurality of pixels with pixel coordinates (xi, yi, zi); Detecting, for each of the plurality of pixels, an intensity of the incident radiation (10); Determining, for each of the plurality of pixels, an incidence direction of the incident radiation using information on an orientation of an internal periodic structure at the pixel and the predetermined intensity distribution, wavelength ? and the detected intensity; and Determining the position (xp, yp, zp) of the radiation source (1) using the pixel coordinates (xi, yi, zi) and the incidence direction for each of the plurality of pixels.
    Type: Grant
    Filed: July 6, 2017
    Date of Patent: February 5, 2019
    Assignees: Brunker Nano GmbH, University of Strathclyde
    Inventors: Aimo Winkelmann, Stefano Vespucci